Concepedia
Statistics
Publications
2
Citations
38
H-Index
Active since
2022
Affiliations
KalVista Pharmaceuticals (United States)(Current)
University of Toronto
Edward J. Duckworth is an author at KalVista Pharmaceuticals (United States).
Publications per year
2022–2022
Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on‐demand treatment of hereditary angioedema
Edward J. Duckworth, Nivetha Murugesan, Lily Li et al. · Clinical & Experimental Allergy · 2022 · 20 citations · Full text
KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results
Andreas Maetzel, Michael D. Smith, Edward J. Duckworth et al. · Journal of Allergy and Clinical Immunology · 2022 · 18 citations
1–2 of 2